Clinical trial · Observational
Pecs II Block and PaB Could be an Alternative in Breast Surgery
Association Between Ultrasound-guided Pecs II Block and Parasternal Block May Represent a Valid Alternative for the Management of Acute and Postoperative Pain Syndrome in Breast Cancer Surgery: a Retrospective Study
NCT02865265CI-TRIAL-00023477completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The association between ultrasound-guided Pecs II block and parasternal block can represent a valid alternative in the management of acute and postoperative pain syndrome after quadrantectomy with or without axillary dissection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pecs II and parasternal blocks | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Pecs II and parasternal blocks
- description
- Pecs II block was performed at the level of the fourth rib in the fascial plane between the minor pectoral and serratus anterior muscles, and 20 ml of 0.5% levobupivacaine solution were injected. An ultrasound-guided ipsilateral PaB was performed via two separate injections of 4 ml of 0.375% levobupivacaine at the level of the 2nd and 4th intercostal space underneath the external intercostal membrane between the major pectoral and intercostal muscles close to the surface of the 2nd and 4th rib.
- interventionNames
- Procedure: Pecs II and parasternal blocks
Primary outcomes (1)
- measure
- Pain
- timeFrame
- Pain was recorded at 24 months after surgery
- description
- Pain has been evaluate with visual analogue scale (VAS) at 24 months after surgery
Secondary outcomes (3)
- measure
- Neuropathic postoperative disturbances
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * 18-75 years of age; * American Society of Anesthesiologists (ASA) physical status I-III, * patients scheduled for quadrantectomy with or without axillary dissection Exclusion Criteria: * pregnancy; * body mass index (BMI) \>35; * allergy to local anesthetics; * skeletal or muscle abnormalities of the chest wall; * presence of primary or secondary neurological diseases; * presence of psychiatric diseases; * history of chronic pain or neuropathic disorders; * history of drug abuse; * state of sepsis; * infection * tumors of the skin on the chest; * primary; * secondary coagulopathies
References
Publications (0)
Data not yet available
No reference posted for this study.